Ajooni Biotech Ltd
Food, Beverages & Tobacco | Small Cap
Ajooni Biotech Ltd, operating in the FMCG sector, showcases a mixed financial performance. The company demonstrates strong solvency and growth, particularly in operating profit, EPS, and asset growth. However, liquidity remains a significant concern, with all liquidity ratios indicating poor performance. Efficiency ratios are also low, except for days sales in inventory and receivable days. Profitability is a mixed bag, with a strong ROCE but weak gross and net margins. Overall, while the company shows potential for growth and manages its equity well, it needs to address its liquidity and efficiency challenges to ensure long-term financial health.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio6.00
- Financial Ratio4.00
- Profitability Ratio4.20
- Efficiency Ratio4.67
- Coverage Ratio3.20
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursBearish
- 4 HoursBearish
- 1 DayBearish
- 1 WeekBearish
- 1 MonthNeutral
Ajooni Biotech Ltd, operating in the FMCG sector, showcases a mixed financial performance. The company demonstrates strong solvency and growth, particularly in operating profit, EPS, and asset growth. However, liquidity remains a significant concern, with all liquidity ratios indicating poor performance. Efficiency ratios are also low, except for days sales in inventory and receivable days. Profitability is a mixed bag, with a strong ROCE but weak gross and net margins. Overall, while the company shows potential for growth and manages its equity well, it needs to address its liquidity and efficiency challenges to ensure long-term financial health.
Overall Valuation Score
P/E RATIO (TTM)
15.08
Industry Median
15.02
Small Cap Median
15.02
P/E RATIO
15.08
P/B RATIO
0.71
Industry Median
2.21
Small Cap Median
2.21
P/S RATIO
0.36
Industry Median
1.01
Small Cap Median
1.01
Others
PEG RATIO
0.00
EV/EBITDA RATIO
7.35
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹3.77 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company shows strong growth in operating profit, EPS, and asset growth. However, revenue and net income growth are stagnant. This indicates the company is becoming more profitable and efficient in its operations, but needs to focus on revenue generation to sustain long-term growth.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 45.1 | 0 | 8.11 | 43.75 | 58.26 |
| Operating Profit Growth Rate | 50 | 0 | -33.33 | 100 | 50 |
| Earnings Per Share (EPS) Growth | 150 | 20 | 100 | 66.67 | 25 |
| Asset Growth Rate | 3.57 | 103.45 | -18.64 | 97.92 | 26.32 |
| Net Income Growth Rate | 0 | 100 | 50 | 33.33 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios reveal a mixed performance. While capital expenditures are well-managed, adjusted EPS, cash EPS, book value per share, and dividend per share are low. These factors indicate the need to enhance earnings, shareholder value, and overall financial stability.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 0.2 | 0.11 | 0.22 | 0.18 | 0.24 |
| Cash Earnings Per Share (Cash EPS) | 0.4 | 0.22 | 0.33 | 0.24 | 0.35 |
| Book Value Per Share | 3.2 | 4.67 | 4.78 | 5.18 | 5.35 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 2 | 2.9 | 5.6 | 1.1 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company exhibits a mixed profitability profile. While ROCE is strong, gross profit, ROE, operating, and net margins are low. Focus on enhancing overall profit margins and operational efficiency to improve overall profitability.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 2.7 | 2.7 | 1.25 | 2.61 | 2.2 |
| Return on Capital Employed (ROCE) | 9 | 6 | 8 | 7 | 6 |
| Return on Equity (ROE) | 6.25 | 2.38 | 4.65 | 3.41 | 4.4 |
| Return on Assets (ROA) | 10.34 | 5.08 | 4.17 | 4.21 | 5 |
| Operating Margin | 4.05 | 4.05 | 2.5 | 3.48 | 3.3 |
| Net Margin | 1.35 | 1.35 | 2.5 | 2.61 | 2.2 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios present a mixed picture. While days sales in inventory and receivable days are well-managed, fixed asset, inventory, receivables, and capital turnover ratios are low. This suggests potential inefficiencies in utilizing assets and managing sales, indicating areas for improvement to enhance overall operational performance.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 12.33 | 12.33 | 8 | 10.45 | 7 |
| Inventory Turnover Ratio | 12.79 | 11.34 | 7.07 | 5.69 | 5.61 |
| Receivables Turnover Ratio | 5.37 | 4.3 | 4.77 | 7.88 | 10.69 |
| Days Sales in Inventory Ratio | 28.54 | 32.19 | 51.63 | 64.15 | 65.06 |
| Receivable Days | 67.97 | 84.88 | 76.52 | 46.32 | 34.14 |
| Capital Turnover Ratio | 3.98 | 1.69 | 1.79 | 1.28 | 1.97 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios indicate a limited ability to cover interest expenses and equity dividends. Though interest coverage is present, the absence of equity dividend coverage raises concerns. This suggests potential financial strain in meeting interest obligations and rewarding shareholders, indicating areas for improvement in financial management.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 2 | N/A | 4 | N/A | 7 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position indicates a strong reliance on equity and minimal debt. This suggests a conservative approach to financing, which can provide stability. The absence of debt reduces financial risk but may also limit opportunities for leveraging growth through borrowing.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.14 | 0.04 | 0.04 | 0.02 | 0.02 |
| Debt to Equity Ratio | 0.16 | 0.04 | 0.04 | 0.02 | 0.02 |
| Equity Ratio | 0.86 | 0.96 | 0.96 | 0.98 | 0.98 |
| Debt To Asset Ratio | 0.09 | 0.03 | 0.03 | 0.02 | 0.01 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position reflects challenges in meeting its short-term obligations. While the company is facing challenges in liquidity, it needs to improve its current assets and liabilities to avoid the risk of not meeting its short-term obligations.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2.25 | 3.11 | 9.74 | 16 | 3.38 |
| Quick Ratio | 1.65 | 2.66 | 5.34 | 11.2 | 1.93 |
| Cash Ratio | 0.01 | 0.02 | 0.12 | 1.37 | 0.02 |
| Operating Cash Flow Ratio | 0.41 | -0.39 | 6.59 | -3.6 | 0 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Baba Food Processing India Ltd | 7.63 | -29.72 | Neutral | 3.00 | 1.88 | -1.00 |
| 2 | Srivari Spices & Foods Ltd | 6.84 | 18.75 | Neutral | 30.00 | 18.87 | 16.00 |
| 3 | Ajooni Biotech Ltd | 4.92 | 15.08 | Neutral | 6.00 | 0.25 | 4.00 |
| 4 | Dangee Dums Ltd | 3.51 | -34.67 | Neutral | 4.91 | -0.09 | -1.39 |
The management of Ajooni Biotech demonstrates a mixed performance. While recent sales and profit growth are positive, concerns exist regarding declining promoter holding and relatively low ROCE. The company's ability to effectively manage working capital also presents a challenge. Overall, while there are positive growth trends, aspects of financial health and ownership structure warrant attention.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 43% (TTM) | Strong sales growth in the recent term |
| Profit Growth | 56% (TTM) | Significant profit growth in the latest term | |
| CONS | Promoter Holding | 26.89% (Mar 2025) | Decreasing promoter confidence |
| ROCE | 7% (Mar 2025) | Low return on capital employed |
Financial Performance & Growth
Ajooni Biotech demonstrates fluctuating sales performance. The compounded sales growth has been strong over the past decade. Compounded profit growth also shows a similar trend. However, the operating profit margin has fluctuated, indicating potential operational inefficiencies.
| Metric | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 | |------------------|------------|------------|--------|--------| | Compounded Sales Growth (%) | 27.67% | 8.33% | 24.33% | 43% | | Compounded Profit Growth (%) | 44.33% | 25.67% | 56% |
Capital Efficiency & Returns
The capital efficiency and returns of Ajooni Biotech are relatively low. The Return on Capital Employed (ROCE) is below industry standards. This indicates that the company is not effectively utilizing its capital to generate profits. The asset turnover ratio and cash conversion cycle also suggest inefficiencies in working capital management.
| Metric | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 17% | 4.67% | 7% | 7% |
Financial Health & Prudence
Ajooni Biotech's financial health shows a mix of stability and potential concern. The company maintains a relatively low debt-to-equity ratio, suggesting controlled leverage. Interest coverage appears adequate.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Borrowings (Cr) | 5 | 5 | 2 | 2 |
Shareholding & Ownership Structure
The shareholding pattern of Ajooni Biotech indicates a decreasing promoter holding. The reduction in promoter stake over the years raises concerns about the alignment of management with shareholders. Institutional holding is also minimal, suggesting limited confidence from institutional investors.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 52.62% | 36.39% | 26.44% | 26.89% |
Ajooni Biotech faces moderate risk due to its cash conversion cycle and decrease in promoter holding. While the company exhibits sales and profit growth, inefficiencies in working capital management and fluctuating operating profit margins contribute to the overall risk profile.
Cash Conversion Cycle
Ajooni Biotech exhibits a high cash conversion cycle, indicating inefficient working capital management. The company takes a significant amount of time to convert its investments in inventory and receivables into cash. A prolonged cash conversion cycle may lead to liquidity issues and increased operational costs.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Cash Conversion Cycle (Days) | 63 | 83 | 131 | 129 |
Promoter Holding
The shareholding pattern of Ajooni Biotech indicates a decreasing promoter holding. The reduction in promoter stake over the years raises concerns. A decreased promoter holding may decrease investors confidence.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 52.62% | 36.39% | 26.44% | 26.89% |
Institutional Holding (FII/DII)
Ajooni Biotech has minimal institutional holding. The lack of significant investment from FIIs and DIIs suggests limited confidence from institutional investors. Low institutional interest may impact stock liquidity and valuation.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| FIIs (%) | 0.00% | 0.01% | 0.00% | 0.00% |
| DIIs (%) | 4.26% | 0.00% | 0.00% | 0.00% |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 103.82Bearish
- SMA 203.82Bearish
- SMA 503.83Bearish
- EMA 103.81Bearish
- EMA 203.82Bearish
- EMA 503.85Bearish
- DEMA 103.80Bearish
- DEMA 203.81Bearish
- DEMA 503.79Bearish
- TEMA 103.79Bearish
- TEMA 203.81Bearish
- TEMA 503.81Bearish
- MACD-0.01Bearish
- ADX36.97Strong Trend
- IndicatorValueSignal
- RSI43.53Neutral
- CCI-178.29Oversold
- ROC 9-1.30Bearish
- ROC 14-0.79Bearish
- ROC 25-1.81Bearish
- Stoch K40.48Neutral
- Stoch D46.46Neutral
- IndicatorValueSignal
- BB Upper3.87Neutral
- BB Middle3.82Neutral
- BB Lower3.77Neutral
- ATR0.06Low Volatility
- IndicatorValueSignal
- MFI18.71Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103.83Bearish
- SMA 203.82Bearish
- SMA 503.87Bearish
- EMA 103.82Bearish
- EMA 203.83Bearish
- EMA 503.89Bearish
- DEMA 103.81Bearish
- DEMA 203.80Bearish
- DEMA 503.78Bullish
- TEMA 103.81Bearish
- TEMA 203.82Bearish
- TEMA 503.77Bullish
- MACD-0.02Bullish
- ADX35.28Strong Trend
- IndicatorValueSignal
- RSI42.55Neutral
- CCI-110.43Oversold
- ROC 9-0.79Bearish
- ROC 14-0.26Bearish
- ROC 25-1.30Bearish
- Stoch K45.24Neutral
- Stoch D60.64Neutral
- IndicatorValueSignal
- BB Upper3.88Neutral
- BB Middle3.82Neutral
- BB Lower3.75Neutral
- ATR0.08Low Volatility
- IndicatorValueSignal
- MFI50.80Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103.81Bearish
- SMA 203.83Bearish
- SMA 504.01Bearish
- EMA 103.82Bearish
- EMA 203.86Bearish
- EMA 503.97Bearish
- DEMA 103.80Bearish
- DEMA 203.78Bullish
- DEMA 503.83Bearish
- TEMA 103.82Bearish
- TEMA 203.79Bullish
- TEMA 50N/AN/A
- MACD-0.06Bullish
- ADX46.45Strong Trend
- IndicatorValueSignal
- RSI40.27Neutral
- CCI-52.35Neutral
- ROC 9-0.79Bearish
- ROC 14-4.29Bearish
- ROC 25-5.49Bearish
- Stoch K42.86Neutral
- Stoch D50.81Neutral
- IndicatorValueSignal
- BB Upper3.97Neutral
- BB Middle3.83Neutral
- BB Lower3.70Neutral
- ATR0.12Low Volatility
- IndicatorValueSignal
- MFI46.35Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103.82Bearish
- SMA 203.96Bearish
- SMA 504.14Bearish
- SMA 1004.27Bearish
- SMA 2004.56Bearish
- EMA 103.84Bearish
- EMA 203.92Bearish
- EMA 504.08Bearish
- EMA 1004.24Bearish
- EMA 2004.60Bearish
- DEMA 103.76Bullish
- DEMA 203.78Bearish
- DEMA 503.90Bearish
- DEMA 1003.91Bearish
- DEMA 2003.90Bearish
- TEMA 103.77Bullish
- TEMA 203.74Bullish
- TEMA 503.84Bearish
- TEMA 1003.95Bearish
- TEMA 2003.77Bullish
- MACD-0.11Bearish
- ADX35.46Strong Trend
- IndicatorValueSignal
- RSI36.50Neutral
- CCI-72.14Neutral
- ROC 14-7.37Bearish
- ROC 25-10.66Bearish
- Stoch K50.68Neutral
- Stoch D48.04Neutral
- IndicatorValueSignal
- BB Upper4.29Neutral
- BB Middle3.96Neutral
- BB Lower3.62Neutral
- ATR0.17Low Volatility
- IndicatorValueSignal
- MFI33.60Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 204.31Bearish
- SMA 504.73Bearish
- EMA 204.25Bearish
- EMA 504.73Bearish
- DEMA 203.96Bearish
- DEMA 504.01Bearish
- TEMA 203.99Bearish
- TEMA 503.76Bullish
- MACD-0.21Bearish
- ADX21.72Weak Trend
- IndicatorValueSignal
- RSI39.24Neutral
- CCI-130.05Oversold
- ROC 14-18.28Bearish
- ROC 25-10.38Bearish
- Stoch K31.06Neutral
- Stoch D31.52Neutral
- IndicatorValueSignal
- BB Upper4.94Neutral
- BB Middle4.31Neutral
- BB Lower3.67Neutral
- ATR0.41High Volatility
- IndicatorValueSignal
- MFI31.63Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 64.14Bullish
- SMA 124.74Bearish
- SMA 245.92Bearish
- EMA 64.29Bearish
- EMA 124.72Bearish
- EMA 245.24Bearish
- DEMA 63.96Bullish
- DEMA 124.01Bullish
- DEMA 244.63Bearish
- TEMA 64.06Bullish
- TEMA 123.76Bullish
- TEMA 244.09Bullish
- MACD-0.21Bearish
- ADX11.39Weak Trend
- IndicatorValueSignal
- RSI44.79Neutral
- CCI-87.45Neutral
- ROC 25-28.20Bearish
- ROC 50-60.33Bearish
- Stoch K16.68Oversold
- Stoch D40.31Neutral
- IndicatorValueSignal
- BB Upper8.19Neutral
- BB Middle5.60Neutral
- BB Lower3.01Neutral
- ATR1.18Low Volatility
- IndicatorValueSignal
- MFI28.91Neutral